Labwire, Inc.
Labwire, Inc.
Your view on LBWR
Overview
What the company does, where it operates, and who runs it.
About Labwire, Inc.
- Industry
- Information Technology Services
- Sector
- Technology
- CEO
- Shin Hwang
- Headquarters
- 1514 FM 359 Road, Phoenix, TX, US
- Industry
- Information Technology Services
- Sector
- Technology
- CEO
- Shin Hwang
- Headquarters
- 1514 FM 359 Road, Phoenix, TX, US
Labwire, Inc., along with its subsidiary, Workplace Screening Services, provides employee screening services for Fortune 500 corporations in the United States. It offers services through Labwire Platform, a Web-based application that streamlines the regulatory and record management activities associated with employee screening.
The company's services include drug testing, employee background screening, drug testing policy analysis and updates, medical review, supervisor training and education, and real-time online data management, as well as Red Flag Compliance program and drug testing program development.
Its Labwire application services include data management and transmission, collection site management and billing consolidation, and custom statistical reports and data transfer.
The company also assists organizations with customized services, including education, client support systems, background checks, physicals, and more. Labwire, Inc. was founded in 2004 and is headquartered in Brookshire, Texas.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Labwire, Inc., and the rating behind it. LBWR last traded at $0.0003; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Labwire, Inc.. Starting points for Labwire, Inc.: beta -123.31 — an Information Technology Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Labwire, Inc.. Labwire, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Labwire, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Labwire, Inc.. Labwire, Inc. has reported as a listed company since 2009. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Labwire, Inc. valued side by side against its closest peers. Labwire, Inc. is measured against Information Technology Services peers within the Technology sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Labwire, Inc., and how their positions are changing. At a $44,353 market value, institutional positions materially move Labwire, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Labwire, Inc. executives and directors. Shares of Labwire, Inc. have traded between $0.0001 and $0.0003 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Labwire, Inc.. Labwire, Inc. is a $44,353 Technology company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Labwire, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Labwire, Inc.. Coverage tracks Labwire, Inc. within Information Technology Services (Technology). Press releases and market coverage, newest first.